SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-22-001281
Filing Date
2022-04-29
Accepted
2022-04-29 06:01:49
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS uthr3994981-defa14a.htm DEFA14A 33264
2 GRAPHIC uthr3994981-defa14a1logo.jpg GRAPHIC 12381
3 GRAPHIC uthr3994981-defa14a1x1x1.jpg GRAPHIC 34764
4 GRAPHIC uthr3994981-defa14a1x1x2.jpg GRAPHIC 5092
5 GRAPHIC uthr3994981-defa14a1x1x3.jpg GRAPHIC 5673
6 GRAPHIC uthr3994981-defa14a1x1x4.jpg GRAPHIC 4878
7 GRAPHIC uthr3994981-defa14a1x2x1.jpg GRAPHIC 1174
  Complete submission text file 0001206774-22-001281.txt   123430
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 22869798
SIC: 2834 Pharmaceutical Preparations